Oncotarget
@Oncotarget
Oncotarget is a peer-reviewed, open-access biomedical journal dedicated to publishing high-quality research. Indexed by MEDLINE, PMC, PubMed, Scopus and others
ID:702864980362702849
http://www.oncotarget.com 25-02-2016 14:37:24
10,8K Tweets
3,2K Followers
3,9K Following
Today's newsletter includes an article from @oncotarget: Predicting Cancer Immunotherapy Response From Gut Microbiomes Using Machine Learning Models || Catch up on the rest of the top oncology news of the day here: aggrego.news
#medtwitter #oncology #immunotherapy
Predicting cancer #immunotherapy response from gut microbiomes using machine learning models - new #CCRAdvance out now Oncotarget. oncotarget.com/article/28252/… @gulleyj1 Andrea Apolo, M.D.
⚡️ Predicting cancer #immunotherapy response from gut microbiomes using machine learning models
Oncotarget @gulleyj1 Andrea Apolo, M.D.
. oncotarget.com/article/28252/…
Clinical validation of the tempus xT next-generation targeted oncology sequencing assay [Mar 22, 2019] Beaubier et al. Oncotarget oncotarget.com/article/26797/… #PrecisionMedicine #oncopath #ImmunoOnc Tempus
For more information on my team's #cancerresearch in #ovariancancer and other similarly aggressive tumor types, check out the Lou Lab website UMN Department of Medicine UMN H.O.T. Division: med.umn.edu/dom/research/l…
Thank you ACS Minnesota!
(Video citation: oncotarget.com/article/9504/t… Oncotarget 2016)
Clinical benefit of a #PrecisionMedicine based approach for guiding treatment of refractory cancers [Jul 15, 2016] Radovich et al. Oncotarget ow.ly/DBXD302mfub
The COVID shutdown has been hard on many researchers. To keep the gears turning we published reviews so UG students gained writing experience. Thanks Oncotarget for sharing one of our stories. lnkd.in/gaSZhCCj
Oncotarget article in today's #APaperADay . This study highlights the suppressive effect of ASK1 on HCC and its significance. These outcomes broaden the knowledge and provide a novel potential prognostic biomarker and therapeutic target for advanced HCC.
oncotarget.com/article/8478/t…
Dick Cheney got heart transplant 10 years ago. Therefore, he is most likely has been taken #rapamycin (sirolimus) or everolimus (rapamycin analog) for the last 10 years. This may explain his longevity!
Watch an #OncotargetShort video about a trending new study aimed at identifying the underlying mechanisms of endocrine resistance in #breastcancer .
Read the full research paper: doi.org/10.18632/oncot…
#breastcancer research #cancer #openaccess #oncology
Watch an #OncotargetShort video about the roles of GATA3 and APOBEC3B in a rare #adrenal gland cancer, #adrenocortical carcinoma.
Read the paper: doi.org/10.18632/oncot…
#openaccess #cancer #cancer research
Dr. John Hawse from the Mayo Clinic discusses his 2017 study published by Oncotarget, entitled, “ERβ inhibits cyclin dependent kinases 1 and 7 in triple negative breast cancer.” oncotarget.org/2021/05/17/beh… #breastcancer #openaccess #science #medicine #medEd #OA #BehindTheStudy